icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Re-assessment of the target population of AFINITOR, in combination with exemestane, in the treatment of advanced breast cancer in postmenopausal women in line with article R-163-19 of the French Social Security Code.
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
sDDmGg3pqLu6zu7H